IGC Pharma IGC Cash Flow Statement (2010-2026)

NYSE IGC
$0.27 +0.00 (+0.30%)
As of: Sep 30, 2026 · 3:59 PM EDT
Reported Financials

IGC Pharma Quarterly Cash Flow Statement

Periods 63 quarters
Latest Mar 2026

IGC Pharma reported cash from operations of -$1.22M and free cash flow of -$1.22M for the quarter ended Mar 2026, up 7.1% year over year. This cash flow statement covers 63 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Mar2026
Operating Activities
Net Income
-2.95M-1.79M-4.34M-2.38M-6.50M-2.79M-2.44M-2.25M-4.03M-2.08M-2.45M-5.59M-2.88M-2.38M-1.72M-1.83M-1.20M-1.60M-1.82M-2.40M
Depreciation and DepletionDep. & Depletion
0.16M0.15M0.16M0.12M0.20M0.15M0.16M0.16M-0.05M0.14M0.14M0.14M0.15M0.14M0.14M0.14M0.14M0.13M0.10M0.04M
Share-based CompensationStock Comp.
0.18M0.81M-0.80M6.96M0.04M6.90M-1.20M-0.20M0.35M0.55M-0.89M4.59M4.60M-0.30M4.70M4.00M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
-0.07M0.02M0.01M0.00M0.01M
Asset Writedowns and ImpairmentWritedown
0.17M0.04M0.80M0.09M0.15M
Cash from OperationsCash from Ops.
-2.50M-1.85M-2.30M-2.42M-0.89M-2.20M-1.69M-1.65M-1.52M-1.47M-1.62M-1.59M-0.53M-1.75M-1.00M-1.32M-0.73M-1.41M-2.09M-1.22M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.17M0.16M0.16M0.17M0.17M0.16M0.17M0.17M0.15M0.15M0.16M0.16M0.16M0.16M0.14M0.16M0.15M0.14M0.12M0.06M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.05M-0.01M-0.02M0.03M-0.04M0.02M0.04M0.06M-0.13M0.12M-0.09M-0.04M0.04M-0.01M0.02M0.01M-0.00M0.05M-0.05M0.02M
Change in InventoryChange Inventory
0.32M-0.00M0.02M-0.07M-1.88M0.07M0.13M-0.00M-1.10M-0.01M-0.01M0.02M-1.02M-0.03M-0.08M-0.07M-0.01M-0.01M
Change in Account PayablesChange Payables
0.77M0.09M-0.15M-0.61M1.17M-0.52M-0.01M0.02M0.07M0.14M-0.12M0.10M0.13M-0.00M-0.00M0.07M0.04M0.05M-0.30M0.24M
Change in Accured ExpensesChange Accured Exp.
0.03M-0.03M-0.03M0.48M0.09M0.09M-0.27M0.28M0.15M0.32M-0.22M-0.45M-0.60M0.09M-0.10M
Other Working Capital ChangesOther WC Changes
0.17M0.03M0.12M0.04M-0.73M-0.07M-0.46M-0.12M0.07M-0.03M-0.04M-0.09M-0.15M0.12M0.11M-0.04M-0.03M-0.18M-0.90M0.04M
Investing Activities
Capital ExpendituresCapex
0.09M0.09M0.03M0.03M0.08M0.13M-0.40M0.58M0.01M0.02M0.04M0.07M0.01M0.04M0.03M0.03M0.02M0.01M0.03M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.54M-0.01M0.04M-0.00M0.00M0.02M0.02M0.70M-0.02M
Change in IntangiblesChange Intangibless
0.03M0.00M0.01M0.02M0.50M0.03M0.03M0.08M0.17M0.03M0.02M0.02M0.31M0.09M0.05M0.08M0.15M0.11M0.30M0.17M
Acquisitions
Change in Acquisitions & DivestmentsChange Acquisitions
-0.10M0.07M-0.03M
Cash from Investing ActivitiesCash from Investing
1.93M-0.10M-0.04M-0.05M-0.55M-0.16M0.18M-0.02M-0.24M-0.01M0.07M-0.06M-0.32M-0.13M-0.07M-0.10M-0.14M0.58M-0.37M-0.17M
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
14.16M0.73M3.42M-0.00M-0.00M-0.00M0.10M-0.00M-0.00M2.86M-0.00M0.67M2.51M0.79M0.34M0.81M0.85M3.11M0.71M
Debt Issuance and Repayment
Non-Current Debt
-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Current Debt
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
14.16M0.73M3.42M0.10M2.86M0.17M2.51M0.80M0.35M0.81M0.85M3.11M0.09M
Additional items
Exchange Rate EffectFX Effect
-0.00M-0.01M0.01M0.01M-0.04M-0.05M-0.03M-0.01M0.01M0.00M-0.01M0.00M0.00M0.00M-0.01M0.00M0.03M0.01M-0.01M
Change in Cash
13.58M-1.23M1.08M-2.46M-1.48M-2.41M-1.43M-1.68M-1.75M-1.47M1.30M-1.65M-0.18M0.63M-0.28M-1.08M-0.07M0.05M0.65M-0.69M
Free Cash FlowFCF
-2.59M-1.94M-2.33M-2.45M-0.97M-2.32M-1.28M-2.23M-1.52M-1.49M-1.65M-1.66M-0.54M-1.79M-1.02M-1.34M-0.75M-1.42M-2.12M-1.22M
Net Cash FlowNCF
13.58M-1.22M1.07M-2.47M-1.44M-2.35M-1.40M-1.67M-1.76M-1.47M1.31M-1.65M-0.18M0.62M-0.27M-1.08M-0.07M0.02M0.65M-0.68M

IGC Pharma Cash Flow Statement API

Pull IGC Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IGC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY